Gynecology Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Gynecology clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting

Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer

Gynecologycal Cancer
Wake Forest University Health Sciences30 enrolled2 locationsNCT07046936
Recruiting
Not Applicable

Surgical Operating Room Enhancement Curriculum for Medical Students

GynecologyOperating RoomsMedical Education
Wayne State University60 enrolled1 locationNCT07006337
Recruiting
Phase 2

First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer

Endometrial CancerEndometrial CarcinomaRecurrent Endometrial Carcinoma+2 more
Yonsei University92 enrolled6 locationsNCT06502743
Recruiting
Not Applicable

Acupuncture for Chronic Pelvic Pain

AcupuncturePelvic PainGynecology
David Moss64 enrolled1 locationNCT06388590
Recruiting

Clinicopathological Analysis of Endometrial Carcinoma in the View of Old and New International Federation of Gynecology and Obestetrics (FIGO)

Endometrial CarcinomaClinicopathologicalFederation of Gynecology and Obestetrics
Assiut University110 enrolled1 locationNCT06632431
Recruiting
Not Applicable

UTERINE EVALUATION FOR THE IDENTIFICATION OF PATHOLOGY. This Study Will Compare the Intrauterine Pathology Detection Rate Between Standard of Care Hydrosonography, and a New Visual Saline Infusion Device Providing Direct Visualization of the Uterus.

Fertility IssuesVisualizationHysteroscopy+3 more
Center for Reproductive Health & Gynecology100 enrolled2 locationsNCT06394752